Latest News from NPR

on:

NCPR is supported by:

 
Hourly Newscast
4 min., 45 sec.

Programs

Latest program rundown

Coming up:

Latest Features:
Getty Images
May 17, 2013 | NPR · His administration has prosecuted six people for giving reporters information about secret national security operations — twice as many cases as all previous presidents combined. Amid criticism from First Amendment advocates, the White House insists it values both press freedoms and national security.
 
May 17, 2013 | NPR · The Justice Department has been scrutinized this week for secretly obtaining phone records of Associated Press reporters and editors while investigating the disclosure of a CIA operation to thwart a terrorist attack. Steve Inskeep talks to Floyd Abrams, a leading First Amendment lawyer, about how the Constitution and the law treat press freedom.
 
May 17, 2013 | NPR · From the Afghan capital Kabul, Morning Edition's Renee Montagne talks to Gen, Joseph Dunford, the commander of all U.S. and international forces there. They discuss the challenges of the current situation on the ground, and look ahead to the withdrawal of NATO combat troops in 2014.
 

Latest program rundown

Coming up:

Latest Features:
Sarah Brodzinski
May 18, 2013 | NPR · More than 5 million Americans currently have Alzheimer's disease, and the number is only going to increase — in part, due to aging baby boomers. But researchers say increased awareness and early detection is helping patients live with the disease.
 
May 18, 2013 | NPR · With the White House embroiled in three concurrent scandals this week, Weekends on All Things Considered host Jacki Lyden speaks with James Fallows, national correspondent with The Atlantic, about the way forward for the president and for Congress, with recent history as their guide.
 
AP
May 18, 2013 | NPR · Fed up with working for free, some interns are suing their employers. Last week, a judge ruled that interns could not sue the Hearst Corp. as a class action, which could be a legal setback for young workers tired of exploitative unpaid internships.
 

Latest Saturday rundown




WE Saturday Feature

AP
May 18, 2013 | NPR · Research shows that prime-time television isn't a bad place to find portrayals of working women. Working moms and working women over 40 are another story.
 

Latest Sunday rundown


WE Sunday Feature

May 19, 2013 | NPR · Controversies dominated this past week's political headlines, leaving the Obama White House on the defensive, trying to contain any lasting damage. Host Rachel Martin talks with NPR's Mara Liasson.
 

Latest program rundown

Coming up:

Pfizer Inc

May 6, 2013 — Men still need a prescription for the diamond-shaped blue pills. But instead of going to the pharmacy in person, or taking their chances buying from an online pharmacy of unknown repute, men will be able to buy Viagra from the maker of the drug itself and have it shipped to their homes.
Comments |
Nov 7, 2012 — Xeljanz, a new rheumatoid arthritis drug, is the first one that works by blocking enzymes called janus kinases. They play a communication role inside the body and are involved in inflammation associated with rheumatoid arthritis.
Comments |
Aug 7, 2012 — Pfizer's research on an experimental drug that attacks plaques in the brain has been discontinued. But scientists say they're hopeful that new treatments that attack a specific protein in plaques will have better success.
Comments |
Jul 6, 2012 — Under an agreement between the drugmaker and the Center for Science in the Public Interest, Pfizer won't make claims about "breast health" or "colon health" for Centrum products. In return, the consumer group agreed not to take legal action.
Comments |
Feb 1, 2012 — Pfizer is recalling 1 million packages of oral contraceptives because of errors in the order or types of pills. The mistakes could leave women at risk for unintended pregnancy.
Comments |
Dec 1, 2011 — Two new generic brands of cholesterol-lowering medication threaten sales to Pfizer's number one selling drug — Lipitor. Good news? More people can afford it now.
Comments |
more Pfizer Inc from NPR